Drug intelligence / Profile preview

Clerodendrum volubile ethanol extract

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Clerodendrum volubile ethanol extract (CVE) is a research-stage botanical extract derived from the leaves or flowers of the *Clerodendrum volubile* plant, locally known as 'Marugbo' or 'Eweta' in Nigeria. It is primarily investigated for its antioxidant, antidiabetic, and organoprotective properties. Preclinical studies in animal models suggest that CVE can mitigate doxorubicin-induced cardiotoxicity and hepatorenal damage by reducing oxidative stress markers such as malondialdehyde (MDA) and enhancing antioxidant defenses like glutathione (GSH) and superoxide dismutase (SOD). Additionally, the extract demonstrates inhibitory activity against enzymes involved in carbohydrate and lipid metabolism, including alpha-glucosidase, pancreatic lipase, and glucose-6-phosphatase, suggesting potential applications in managing diabetes and obesity. The chemical profile of the extract, characterized by gas chromatography-mass spectrometry (GC-MS), includes various secondary metabolites that contribute to its biological effects.

Other names
Marugbo extractEweta extract
02

Targets

PNLIP (Pancreatic triacylglycerol lipase)G6PC1 (Glucose 6-phosphatase alpha)Sucrase-Isomaltase

Beyond the preview

Go deeper on Clerodendrum volubile ethanol extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clerodendrum volubile ethanol extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call